Stage I Invasive Lobular Carcinoma: Judith's Survivor Story

This breast cancer diagnosis at a glance

Stage at diagnosis
Stage I
Subtype
Invasive Lobular Carcinoma
Sex
Female
Outcome
Survivorship / Completed Treatment

What happened, in summary

Judith had a strong family history of breast cancer, including grandmothers, her mother, and her 21-year-old daughter. As a biologist, she was careful about diet, exercise, time outdoors, spiritual practice, and stress, and she knew that dense breasts could make mammograms less effective. When routine mammograms raised questions, sonograms had often been used for more sensitive follow-up, so she added low-cost sonograms to her own screening routine. In June 2021, one of those sonograms found an anomaly. Judith brought the finding to her local cancer clinic, where it was identified as what appeared to be very early Stage I invasive lobular carcinoma. She then studied ILC literature and learned that lobular breast cancer can behave differently from ductal breast cancers and may require different thinking about care. LBCA resources helped her read the scientific literature, watch expert panels, and prepare questions for her oncologist. Because her local hospital treated ductal and lobular cancers the same way, Judith self-referred to a hospital system 4 hours away with more ILC experience. As of April 2024, she felt she was cancer-free while still respecting that ILC can be sneaky over time. Her story emphasizes supplemental imaging, subtype-specific care, and informed self-advocacy. Her experience shows why people with dense breasts may seek additional imaging when something feels unresolved.

Where this story comes from

This is a lay summary of an account first published by Lobular Breast Cancer Alliance. Read the original in full

How we source and attribute stories Accuracy and limitations

Similar breast cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more breast cancer stories